Hematology and Cardio-Oncology

Cardiovascular problems vis-à-vis blood and the immune system that provides laboratory values regarding blood, the cardiovascular system and secures cardiovascular diseases from the Chinese medicine and western medicine perspectives.

Cardio-Oncology is to find a balance between oncologic efficacy and reducing antagonistic cardiovascular effects over timely publication and broadcasting of research. Cardiac imaging and transthoracic echocardiography play a crucial role in the baseline assessment and serial follow-up of cardio-oncology patients. Scientific indication in the administration of cardiovascular hitches of onco-hematological patients is unusual, as these patients have been systematically omitted from clinical trials and up-to-date approvals are based on expert consent. Cardio-onco-hematology which allow its claim in regular clinical preparation so to promote the expansion of local multidisciplinary crews, to rally the cardiovascular health of patients with cancer.

  • Amyloid cardiomyopathy
  • Echocardiographic
  • Cardiotoxicity
  • Chemotherapy
  • Cancer Genomics

Related Conference of Hematology and Cardio-Oncology

August 07-08, 2020

World Summit on Hematology and Cell Therapy

Osaka, Japan
November 15-16, 2020

World Hematology 2020

Paris, France
November 23-24, 2020

Annual Hematology Congress

Dubai, UAE

Hematology and Cardio-Oncology Conference Speakers

Recommended Sessions

Related Journals

Are you interested in